title: Effect of Weikangning on gastric cancer cell growth and expression of vascular endothelial growth factor and its receptors KDR and Flt-1.
abstract: OBJECTIVE
  To observe the effect of Chinese traditional herbal decoction Weikang-ning (WKN) on cell growth and expression of VEGF and its receptors KDR and Flt-1 in gastric cancer cell line MGC-803.
  
  
  METHODS
  A total of 120 male Wistar rats were divided into control group, high dose, medium dose and low dose groups fed with natural saline, 20, 10, and 5 g/kg of WKN, respectively. The experimental animals were finally killed for the preparation of drug-containing serum. The gastric cancer cell MGC-803 was cultured with the drug-containing serum drawn from the rats in different groups. We observed the growth condition of the cancer cells with light microscope and flow cytometer. The expression of mRNA of VEGF and its receptors KDR and Flt-1 was detected with RT-PCR.
  
  
  RESULTS
  The proportion of cells in G(0)-G(1) phase was (65.40+/-0.41)%, (56.92+/-0.62)%, (55.89+/-0.69)% in high, medium and low dose groups respectively vs (41.35+/-0.55)% in control group (P<0.01), while the cells in G(2)-S and S phases were (11.62+/-0.62)% and (22.99+/-0.69)%, (17.08+/-0.80)% and (26.00+/-0.71)%, (19.37+/-0.57)% and (24.74+/-0.64)% in high, medium and low dose groups, respectively, vs (23.65+/-0.56)% and (35.00+/-0.60)% in control group (P<0.01). The expression of mRNA of VEGF and its receptors was significantly decreased, the area of electrophoresis bands (AREA), the absorptivity of mean optical density (A) and the product of AREA and A were significantly lower in WKN-administered groups than that in control group (P<0.01).
  
  
  CONCLUSIONS
  The decoction of WKN suppresses the growth of gastric cancer cell MGC-803 and decreases the expression of mRNA of both VEGF and its receptors KDR and Flt-1.
authors.affiliation: Department of Integrative Traditional Chinese Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, Guangdong Province, China. kanfj@yahoo.com.cn
authors.forename: Qing-Ming
authors.initials: QM
authors.lastname: Li
authors.forename: Fang-Ju
authors.initials: FJ
authors.lastname: Kan
authors.forename: Cun-Yun
authors.initials: CY
authors.lastname: Min
mesh_terms: D000818:Animals; D002455:Cell Division / Q000187:drug effects; D045744:Cell Line, Tumor; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017208:Rats, Wistar; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000235:genetics*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000235:genetics*
chemical_list: D004365:Drugs, Chinese Herbal; D012333:RNA, Messenger; D042461:Vascular Endothelial Growth Factor A; D040281:Vascular Endothelial Growth Factor Receptor-1; D040301:Vascular Endothelial Growth Factor Receptor-2
references.citation: J Clin Invest. 2002 Mar;109(6):777-85
references.pmid: 11901186
references.citation: Annu Rev Physiol. 2001;63:49-76
references.pmid: 11181948
references.citation: Int Rev Cytol. 2001;204:49-95
references.pmid: 11243597
references.citation: Eur Surg Res. 2000;32(3):177-81
references.pmid: 10878459
references.citation: J Tradit Chin Med. 2003 Sep;23(3):220-4
references.pmid: 14535198
references.citation: Indian J Gastroenterol. 2000 Apr-Jun;19(2):74-8
references.pmid: 10812820
references.citation: Zhonghua Zhong Liu Za Zhi. 2002 Jan;24(1):4-8
references.pmid: 11977635
references.citation: Leukemia. 2003 Jan;17(1):52-9
references.pmid: 12529660
references.citation: Blood. 2001 Sep 15;98(6):1904-13
references.pmid: 11535528
references.citation: Jpn J Clin Oncol. 2003 Jan;33(1):21-7
references.pmid: 12604720
references.citation: Cancer Chemother Pharmacol. 2003 Apr;51(4):321-7
references.pmid: 12721760
references.citation: Endocr Rev. 1997 Feb;18(1):4-25
references.pmid: 9034784
references.citation: BMC Cancer. 2002 Dec 26;2:36
references.pmid: 12502433
references.citation: Aliment Pharmacol Ther. 2003 Mar 1;17(5):655-64
references.pmid: 12641514
references.citation: Jpn J Cancer Res. 2000 Jul;91(7):748-52
references.pmid: 10920283
references.citation: Pancreas. 1999 Apr;18(3):225-30
references.pmid: 10206479
references.citation: Eur J Cancer. 2001 May;37(7):918-23
references.pmid: 11313181
references.citation: Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003 Dec;23(12):908-10
references.pmid: 14714361
references.citation: Cancer Radiother. 2002 Nov;6 Suppl 1:24s-28s
references.pmid: 12587379
references.citation: J Surg Oncol. 2001 Oct;78(2):132-7
references.pmid: 11579392
references.citation: Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001 Apr;21(4):286-90
references.pmid: 12577360
references.citation: Cancer Sci. 2003 Jan;94(1):43-9
references.pmid: 12708473
references.citation: Recent Results Cancer Res. 2003;162:65-72
references.pmid: 12790321
references.citation: Surgery. 2000 Sep;128(3):408-16
references.pmid: 10965312
references.citation: Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001 Jun;21(6):424-6
references.pmid: 12577436
references.citation: Trop Med Int Health. 2000 Oct;5(10):722-31
references.pmid: 11044267
references.citation: Science. 1999 Dec 17;286(5448):2287-8
references.pmid: 10636791
references.citation: Br J Cancer. 2003 Mar 10;88(5):796-802
references.pmid: 12618892
references.citation: Biochem Biophys Res Commun. 2001 Aug 24;286(3):505-12
references.pmid: 11511087